Suzhou BlueHorse Therapeutics Co., Ltd. | ClinicalTrials HQ

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase II Trial of LM103 in Advanced Melanoma	Advanced Melanoma	Recruiting	Phase 2	2026-08-31		NCT07310784
A Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Phase 2	2026-05-13		NCT07444437
An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid Tumours	Solid Cancer	Recruiting	Early phase 1	2024-11-20		NCT06697665
An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours	Solid Tumor	Recruiting	Early phase 1	2024-11-19		NCT06695689
A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, bronchial neoplasm, bronchogenic carcinoma, cervical carcinoma, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm, uterine disorder	Recruiting	Phase 1	2022-08-02		NCT05366478